Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL30258754

NC(=O)c1cn2ccnc2cn1.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 1/20 0.39
MCHR1 Q99705 1/20 0.36
ENPP1 P22413 1/20 0.36
TGFBR1 P36897 2/20 0.35
DPP4 P27487 1/20 0.34
SYK P43405 2/20 0.33
CBLB Q13191 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
TSHR P16473 1/20 0.33
MC4R P32245 1/20 0.33
ADRA1A P35348 1/20 0.33
MC3R P41968 1/20 0.33
KEAP1 Q14145 1/20 0.33
SIRT6 Q8N6T7 1/20 0.33
RET P07949 1/20 0.32
ESR1 P03372 1/20 0.32
PDCD1 Q15116 1/20 0.32
CD274 Q9NZQ7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21500646 0.89 NAMPT (0.44) NAMPTKMT2AENPP1TGFBR1SYK
Hydrochloric Acid SCHEMBL31250002 0.88 NAMPT (0.43) NAMPTKMT2AENPP1TGFBR1SYK
Trifluoroacetic Acid SCHEMBL30804022 0.79 NAMPT (0.42) NAMPTL3MBTL1KMT2AMCHR1DPP4
SCHEMBL10185196 0.78 NAMPT (0.48) NAMPTL3MBTL1KMT2AENPP1CBLB
Trifluoroacetic Acid SCHEMBL29651920 0.77 MCHR1 (0.49) NAMPTL3MBTL1KMT2AMCHR1DPP4
Hydrochloric Acid SCHEMBL6418044 0.77 NAMPT (0.47) NAMPTL3MBTL1KMT2AENPP1CBLB
SCHEMBL24574436 0.76 NAMPT (0.37) NAMPTKMT2AMCHR1ENPP1CBLB
Trifluoroacetic Acid SCHEMBL30928298 0.75 L3MBTL1 (0.35) L3MBTL1MCHR1DPP4
SCHEMBL17324577 0.73 NAMPT (0.39) NAMPTKMT2AENPP1TGFBR1SYK
SCHEMBL17169816 0.73 NAMPT (0.44) NAMPTKMT2AMCHR1ENPP1TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118063470-A Condensed imidazole derivatives substituted with tertiary hydroxyl groups as PI 3K-gamma inhibitors 因赛特公司 2024-05-24 CN disclosed
CN-111542526-B Condensed imidazole derivatives substituted with tertiary hydroxyl groups as PI 3K-gamma inhibitors 因赛特公司 2024-01-09 CN disclosed
US-20230087118-A1 IMIDAZO[1,2-a]PYRIDINYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE BIOGEN MA INC. 2023-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230087118-A1 IMIDAZO[1,2-a]PYRIDINYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE IRAK4, IRAK2, IRAK1 NAMPT 2282/4885L3MBTL1 1726/4885KMT2A 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.